Patients

Patient-centered by design

Patients are at the heart of everything we do. From the earliest stages of research through clinical development, we actively engage with patient advocacy groups to ensure our development efforts reflect the lived experience of people with the conditions for which we develop new medicines.

• Empathy-first development delivering disease-modifying therapies with better outcomes for patients and their families.
• Engagement with patient advocacy groups as experts and partners by experience.
• Commitment to a patient-centric trial design that meaningfully incorporates patient perspectives and preferences into every aspect of the studies.